Whether it’s in cardiovascular disease, Alzheimer’s or osteoarthritis, therapeutic innovations to target the mechanisms of aging are making significant headway to clinical trials. With increased investments and recognition, along with the escalation of the burden of age-related disease, research and development to meet this unmet medical need has never been more important.

The 5th Age-Related Disease Therapeutics Summit is the only industry-focused meeting dedicated to uniting 60+ biopharma drug developers, pioneering academics, and prominent investors striving to develop effective, novel drugs that promote healthy aging and overcome major translational and regulatory obstacles.

Jam-packed with the most cutting-edge insights and opportunities to reunite with and hear from your peers on the next steps forward in developing the safest and most efficacious drug to promote a healthier and enhanced quality of life.